154 related articles for article (PubMed ID: 38505994)
1. Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors.
Bo Y; Zhao X; Li L
Clin Sci (Lond); 2024 Mar; 138(6):413-434. PubMed ID: 38505994
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development.
Shoeib AM; Yarbrough AL; Ford BM; Franks LN; Urbaniak A; Hensley LL; Benson LN; Mu S; Radominska-Pandya A; Prather PL
Life Sci; 2021 Nov; 285():119993. PubMed ID: 34592231
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands.
Davis MP
Expert Opin Investig Drugs; 2014 Aug; 23(8):1123-40. PubMed ID: 24836296
[TBL] [Abstract][Full Text] [Related]
4. Quetiapine induces myocardial necroptotic cell death through bidirectional regulation of cannabinoid receptors.
Li X; Peng Z; Zhou Y; Wang J; Lin X; Dong X; Liu X; Jiang J; Jiang Y; Li L
Toxicol Lett; 2019 Oct; 313():77-90. PubMed ID: 31220554
[TBL] [Abstract][Full Text] [Related]
5. Assessment of rimonabant-like adverse effects of purported CB1R neutral antagonist / CB2R agonist aminoalkylindole derivatives in mice.
Tai S; Vasiljevik T; Sherwood AM; Eddington S; Wilson CD; Prisinzano TE; Fantegrossi WE
Drug Alcohol Depend; 2018 Nov; 192():285-293. PubMed ID: 30300803
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.
Pacher P; Steffens S; Haskó G; Schindler TH; Kunos G
Nat Rev Cardiol; 2018 Mar; 15(3):151-166. PubMed ID: 28905873
[TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of cannabinoid ligand-induced modulations in intracellular Ca
Xia KK; Shen JX; Huang ZB; Song HM; Gao M; Chen DJ; Zhang SJ; Wu J
Acta Pharmacol Sin; 2019 Mar; 40(3):410-417. PubMed ID: 30202013
[TBL] [Abstract][Full Text] [Related]
8. Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects.
Hu SJ; Cheng G; Zhou H; Zhang Q; Zhang QL; Wang Y; Shen Y; Lian CX; Ma XQ; Zhang QY; Qin LP
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163968
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms for the Risk of Acute Coronary Syndrome and Arrhythmia Associated With Phytogenic and Synthetic Cannabinoid Use.
Richards JR
J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):508-522. PubMed ID: 32588641
[TBL] [Abstract][Full Text] [Related]
10. Clinical Effects of Synthetic Cannabinoid Receptor Agonists Compared with Marijuana in Emergency Department Patients with Acute Drug Overdose.
Zaurova M; Hoffman RS; Vlahov D; Manini AF
J Med Toxicol; 2016 Dec; 12(4):335-340. PubMed ID: 27255136
[TBL] [Abstract][Full Text] [Related]
11. Effect of Cannabinoid Receptor Agonists on Isolated Rat Atria.
Maggo S; Ashton JC
J Cardiovasc Pharmacol; 2018 Oct; 72(4):191-194. PubMed ID: 30080756
[TBL] [Abstract][Full Text] [Related]
12. Opposite effects of cannabinoid CB
Li L; Dong X; Tu C; Li X; Peng Z; Zhou Y; Zhang D; Jiang J; Burke A; Zhao Z; Jin L; Jiang Y
Br J Pharmacol; 2019 Apr; 176(7):890-905. PubMed ID: 30707759
[TBL] [Abstract][Full Text] [Related]
13. Structural basis of selective cannabinoid CB
Li X; Chang H; Bouma J; de Paus LV; Mukhopadhyay P; Paloczi J; Mustafa M; van der Horst C; Kumar SS; Wu L; Yu Y; van den Berg RJBHN; Janssen APA; Lichtman A; Liu ZJ; Pacher P; van der Stelt M; Heitman LH; Hua T
Nat Commun; 2023 Mar; 14(1):1447. PubMed ID: 36922494
[TBL] [Abstract][Full Text] [Related]
14. The Leu/Val
Llinas Del Torrent C; Raïch I; Gonzalez A; Casajuana-Martin N; Lillo J; Rebassa JB; Ferreiro-Vera C; Sánchez de Medina V; Franco R; Navarro G; Pardo L
J Chem Inf Model; 2023 Sep; 63(18):5927-5935. PubMed ID: 37644761
[TBL] [Abstract][Full Text] [Related]
15. CB1 and CB2 receptors are novel molecular targets for Tamoxifen and 4OH-Tamoxifen.
Prather PL; FrancisDevaraj F; Dates CR; Greer AK; Bratton SM; Ford BM; Franks LN; Radominska-Pandya A
Biochem Biophys Res Commun; 2013 Nov; 441(2):339-43. PubMed ID: 24148245
[TBL] [Abstract][Full Text] [Related]
16. Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects.
Liu QR; Canseco-Alba A; Liang Y; Ishiguro H; Onaivi ES
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33371336
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
Theocharis S; Giaginis C; Alexandrou P; Rodriguez J; Tasoulas J; Danas E; Patsouris E; Klijanienko J
Tumour Biol; 2016 Mar; 37(3):3647-56. PubMed ID: 26459312
[TBL] [Abstract][Full Text] [Related]
18. Roles of cannabinoid CB1 and CB2 receptors in the modulation of psychostimulant responses.
Gobira PH; Joca SR; Moreira FA
Acta Neuropsychiatr; 2024 Apr; 36(2):67-77. PubMed ID: 35993329
[TBL] [Abstract][Full Text] [Related]
19. Continuous Intrathecal Infusion of Cannabinoid Receptor Agonists Attenuates Nerve Ligation-Induced Pain in Rats.
Shiue SJ; Peng HY; Lin CR; Wang SW; Rau RH; Cheng JK
Reg Anesth Pain Med; 2017; 42(4):499-506. PubMed ID: 28492437
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid-sensitive receptors in cardiac physiology and ischaemia.
Puhl SL
Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118462. PubMed ID: 30890410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
